| ID | 66075 |
| Title Alternative | 腫瘍融解ウイルスによる骨髄由来抑制細胞の減少は、ゲムシタビン耐性膵臓がんにおけるPD-L1阻害の有効性を高める
|
| FullText URL | |
| Author |
KAJIWARA, Yoshinori
Graduate School of Medicine, Dentistry and Pharmaceutical Sciences, Okayama University
|
| Note | 岡山大学審査学位論文
This is an Accepted Manuscript of the article: Kajiwara, Y., Tazawa, H., Yamada, M. et al. Oncolytic virus-mediated reducing of myeloid-derived suppressor cells enhances the efficacy of PD-L1 blockade in gemcitabine-resistant pancreatic cancer. Cancer Immunol Immunother 72, 1285–1300 (2023). https://doi.org/10.1007/s00262-022-03334-x
This version of the article has been accepted for publication, after peer review (when applicable) and is subject to Springer Nature’s AM terms of use, but is not the Version of Record and does not reflect post-acceptance improvements, or any corrections. The Version of Record is available online at: http://dx.doi.org/10.1007/s00262-022-03334-x
|
| Published Date | 2023-09-25
|
| Content Type |
Thesis or Dissertation
|
| Grant Number | 甲第6908号
|
| Granted Date | 2023-09-25
|
| Thesis Type |
Doctor of Philosophy in Medical Science
|
| Grantor | 岡山大学
|
| Thesis FullText |
Thesis or Dissertation (See FullText URL)
|
| Related Url | isVersionOf https://doi.org/10.1007/s00262-022-03334-x
|
| language |
English
|
| File Version | ETD
|
| Grant ID | 15301甲第6908号
|
| PubMed ID | |
| Copyright Holders | © The Author(s), under exclusive licence to Springer-Verlag GmbH Germany, part of Springer Nature 2022
|
| DOI |
